New Open Source Drug Discovery Initiative Takes Aim At “Devastating” Disease 07/02/2018 by Intellectual Property Watch 3 Comments A consortium including the Drugs for Neglected Disease initiative has launched a groundbreaking open source drug discovery project as way to find new drugs to treat mycetoma, a “devastating disease for which current treatments are ineffective, expensive, and toxic,” the group said.
Gavi-Harvard Study Shows Vaccines Will Save Tens Of Millions From Poverty 05/02/2018 by Intellectual Property Watch Leave a Comment Vaccination will help prevent some 24 million people from falling into poverty by 2030 in addition to saving millions of lives, shows a new study co-authored by Harvard University and Gavi, the Vaccine Alliance.
Biosimilar Industry Launches Information Campaign For Better Acceptance 05/02/2018 by Intellectual Property Watch 1 Comment The International Generic and Biosimilar medicines Association has launched an information campaign on biosimilar medicines in order to raise worldwide understanding and acceptance of biosimilar medicines.
FIND Announces Four New Collaborations To Address AMR 31/01/2018 by Intellectual Property Watch Leave a Comment The Foundation for Innovative New Diagnostics (FIND) yesterday announced the release of a new strategy on antimicrobial resistance (AMR).
Industry Alliance Report: Companies Invest In AMR R&D, Need More Pull Incentives 18/01/2018 by Intellectual Property Watch 1 Comment An alliance of over a hundred industries seeking to curb antimicrobial resistance launched its first report today. According to the report, a number of companies are heavily investing in research and development, and work to improve access to their diagnostic products and preventing therapies.
INTA 4-Year Strategic Plan: Value, Consumer Trust, Innovation 17/12/2017 by Intellectual Property Watch 1 Comment The International Trademark Association (INTA) will implement a new strategic plan for 2018 to 2021 starting with the new year. The plan focuses on promoting the value of trademarks and brands, reinforcing consumer trust, and embracing innovation and change.
Medicines Patent Pool Expands Its Patent Database To Cancer Treatments 12/12/2017 by Intellectual Property Watch Leave a Comment The Medicines Patent Pool (MPP) announced today that MedsPaL, its database of information on the patent and licensing status of selected HIV, hepatitis C, and tuberculosis medicines, now extends to patented treatments on the World Health Organization Model List of Essential Medicines. New patents data include medicines for leukaemia, breast cancer and other cancer indications.
EPO Study Shows Rise In Patents On Next Generation Technologies 11/12/2017 by Intellectual Property Watch Leave a Comment The European Patent Office (EPO) today announced a study that showed “European patent applications related to smart connected objects are rising rapidly, achieving a growth rate of 54% in the last three years.”
EU Parliament Justice Committee Ponders Regulation Of Copyright And Liability In 3D Printing 07/12/2017 by Intellectual Property Watch Leave a Comment Should the European Parliament consider regulation on 3D printing with regard to intellectual property protection and civil liability? Members of the Justice Committee (JURI) today at their session in Brussels were divided with representatives from the Green Party group as well as the conservatives and liberals cautioning against erecting barriers to the technology.
INTA Paper On Brexit Calls For Minimal Disruption, Strong IP Protection 28/11/2017 by Intellectual Property Watch Leave a Comment The International Trademark Association (INTA) today issued a position paper calling for “minimal disruption” and strong intellectual property rights protection as the negotiations proceed on the departure of the United Kingdom from the European Union, known as Brexit. The paper lists core principles and specific recommendations related to IP for both the UK and the EU.